Position in LXEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,192,338
+$3,428,519 QoQ
Shares Held
1,949,885
+149.4% QoQ
Ownership
2.48%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in LXEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. LXEO ranks #133 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in LXEO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,192,338 | 1,949,885 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,763,819 | 781,855 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $945,549 | 142,402 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $146,198 | 36,368 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $274,504 | 79,108 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $598,127 | 90,901 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $693,828 | 76,751 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $430,721 | 26,853 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $369,405 | 23,559 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||